Jikilani, Sal .

HRN: 26-96-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2026
CEFUROXIME 1.5GM (VIAL)
03/21/2026
03/28/2026
IV
450mg
Q8
URTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: